151 related articles for article (PubMed ID: 26477271)
1. Enhancer repertoires are reshaped independently of early priming and heterochromatin dynamics during B cell differentiation.
Choukrallah MA; Song S; Rolink AG; Burger L; Matthias P
Nat Commun; 2015 Oct; 6():8324. PubMed ID: 26477271
[TBL] [Abstract][Full Text] [Related]
2. Immunogenetics. Chromatin state dynamics during blood formation.
Lara-Astiaso D; Weiner A; Lorenzo-Vivas E; Zaretsky I; Jaitin DA; David E; Keren-Shaul H; Mildner A; Winter D; Jung S; Friedman N; Amit I
Science; 2014 Aug; 345(6199):943-9. PubMed ID: 25103404
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated hematopoiesis caused by mammary cancer is associated with epigenetic changes and hox gene expression in hematopoietic cells.
Sio A; Chehal MK; Tsai K; Fan X; Roberts ME; Nelson BH; Grembecka J; Cierpicki T; Krebs DL; Harder KW
Cancer Res; 2013 Oct; 73(19):5892-904. PubMed ID: 23913828
[TBL] [Abstract][Full Text] [Related]
4. Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription during Hematopoiesis.
Huang J; Liu X; Li D; Shao Z; Cao H; Zhang Y; Trompouki E; Bowman TV; Zon LI; Yuan GC; Orkin SH; Xu J
Dev Cell; 2016 Jan; 36(1):9-23. PubMed ID: 26766440
[TBL] [Abstract][Full Text] [Related]
5. Early enhancer establishment and regulatory locus complexity shape transcriptional programs in hematopoietic differentiation.
González AJ; Setty M; Leslie CS
Nat Genet; 2015 Nov; 47(11):1249-59. PubMed ID: 26390058
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment.
Romano O; Peano C; Tagliazucchi GM; Petiti L; Poletti V; Cocchiarella F; Rizzi E; Severgnini M; Cavazza A; Rossi C; Pagliaro P; Ambrosi A; Ferrari G; Bicciato S; De Bellis G; Mavilio F; Miccio A
Sci Rep; 2016 Apr; 6():24724. PubMed ID: 27095295
[TBL] [Abstract][Full Text] [Related]
7. Brg1 modulates enhancer activation in mesoderm lineage commitment.
Alexander JM; Hota SK; He D; Thomas S; Ho L; Pennacchio LA; Bruneau BG
Development; 2015 Apr; 142(8):1418-30. PubMed ID: 25813539
[TBL] [Abstract][Full Text] [Related]
8. A microfluidic device for epigenomic profiling using 100 cells.
Cao Z; Chen C; He B; Tan K; Lu C
Nat Methods; 2015 Oct; 12(10):959-62. PubMed ID: 26214128
[TBL] [Abstract][Full Text] [Related]
9. Active enhancers are delineated de novo during hematopoiesis, with limited lineage fidelity among specified primary blood cells.
Luyten A; Zang C; Liu XS; Shivdasani RA
Genes Dev; 2014 Aug; 28(16):1827-39. PubMed ID: 25128499
[TBL] [Abstract][Full Text] [Related]
10. Heterochromatin and Polycomb as regulators of haematopoiesis.
Keenan CR
Biochem Soc Trans; 2021 Apr; 49(2):805-814. PubMed ID: 33929498
[TBL] [Abstract][Full Text] [Related]
11. Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors.
Mercer EM; Lin YC; Benner C; Jhunjhunwala S; Dutkowski J; Flores M; Sigvardsson M; Ideker T; Glass CK; Murre C
Immunity; 2011 Sep; 35(3):413-25. PubMed ID: 21903424
[TBL] [Abstract][Full Text] [Related]
12. Chromatin modifications in hematopoietic multipotent and committed progenitors are independent of gene subnuclear positioning relative to repressive compartments.
Guillemin C; Maleszewska M; Guais A; Maës J; Rouyez MC; Yacia A; Fichelson S; Goodhardt M; Francastel C
Stem Cells; 2009 Jan; 27(1):108-15. PubMed ID: 18974210
[TBL] [Abstract][Full Text] [Related]
13. PLZF limits enhancer activity during hematopoietic progenitor aging.
Poplineau M; Vernerey J; Platet N; N'guyen L; Hérault L; Esposito M; Saurin AJ; Guilouf C; Iwama A; Duprez E
Nucleic Acids Res; 2019 May; 47(9):4509-4520. PubMed ID: 30892634
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs modulate hematopoietic lineage differentiation.
Chen CZ; Li L; Lodish HF; Bartel DP
Science; 2004 Jan; 303(5654):83-6. PubMed ID: 14657504
[TBL] [Abstract][Full Text] [Related]
15. Scl binds to primed enhancers in mesoderm to regulate hematopoietic and cardiac fate divergence.
Org T; Duan D; Ferrari R; Montel-Hagen A; Van Handel B; Kerényi MA; Sasidharan R; Rubbi L; Fujiwara Y; Pellegrini M; Orkin SH; Kurdistani SK; Mikkola HK
EMBO J; 2015 Mar; 34(6):759-77. PubMed ID: 25564442
[TBL] [Abstract][Full Text] [Related]
16. The role of chromatin dynamics in immune cell development.
Winter DR; Amit I
Immunol Rev; 2014 Sep; 261(1):9-22. PubMed ID: 25123274
[TBL] [Abstract][Full Text] [Related]
17. Blueprint of human thymopoiesis reveals molecular mechanisms of stage-specific TCR enhancer activation.
Cieslak A; Charbonnier G; Tesio M; Mathieu EL; Belhocine M; Touzart A; Smith C; Hypolite G; Andrieu GP; Martens JHA; Janssen-Megens E; Gut M; Gut I; Boissel N; Petit A; Puthier D; Macintyre E; Stunnenberg HG; Spicuglia S; Asnafi V
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32667968
[TBL] [Abstract][Full Text] [Related]
18. Mechanical regulation of transcription controls Polycomb-mediated gene silencing during lineage commitment.
Le HQ; Ghatak S; Yeung CY; Tellkamp F; Günschmann C; Dieterich C; Yeroslaviz A; Habermann B; Pombo A; Niessen CM; Wickström SA
Nat Cell Biol; 2016 Aug; 18(8):864-75. PubMed ID: 27398909
[TBL] [Abstract][Full Text] [Related]
19. Role of Polycomb RYBP in Maintaining the B-1-to-B-2 B-Cell Lineage Switch in Adult Hematopoiesis.
Calés C; Pavón L; Starowicz K; Pérez C; Bravo M; Ikawa T; Koseki H; Vidal M
Mol Cell Biol; 2015 Dec; 36(6):900-12. PubMed ID: 26711264
[TBL] [Abstract][Full Text] [Related]
20. Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3' enhancer.
Muto A; Hoshino H; Madisen L; Yanai N; Obinata M; Karasuyama H; Hayashi N; Nakauchi H; Yamamoto M; Groudine M; Igarashi K
EMBO J; 1998 Oct; 17(19):5734-43. PubMed ID: 9755173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
